Detalles de la búsqueda
1.
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials.
BMC Cancer
; 21(1): 549, 2021 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-33985435
2.
Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer.
Pulm Ther
; 7(2): 295-308, 2021 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-34089169
3.
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data.
In Vivo
; 34(4): 2009-2014, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32606174
4.
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis.
Ecancermedicalscience
; 14: 1113, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33144881
5.
Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. The DISTAL-2 randomized trial.
Lung Cancer
; 63(2): 251-8, 2009 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18632181
6.
Evolution of therapy decision-making process for advanced non-small cell lung cancer.
Oncology
; 77 Suppl 1: 97-102, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-20130437
7.
Listening understanding and acting (lung): focus on communicational issue in thoracic oncology.
Transl Cancer Res
; 8(Suppl 1): S16-S22, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-35117061
8.
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study.
Lung Cancer
; 81(1): 77-83, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23643177
9.
First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial.
J Clin Oncol
; 30(24): 3002-11, 2012 Aug 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-22778317
10.
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer.
J Thorac Oncol
; 7(12): 1830-1844, 2012 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-23154555
11.
First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: a quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale.
Lung Cancer
; 69(2): 218-24, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19910076
Resultados
1 -
11
de 11
1
Próxima >
>>